PLAUR and non-small cell lung carcinoma: While HIF1A transcript levels do not predict poor survival, elevated expression of its downstream targets, including GLUT3, ADM, PLAUR, and CA9, correlate with worse overall survival among NSCLC patients (Fig 3).